Navigation Links
CELLECTA, INC. Announces Launch of Human Whole Genome CRISPR Knockout Library
Date:7/30/2015

MOUNTAIN VIEW, Calif., July 30, 2015 /PRNewswire/ -- Cellecta, Inc., a U.S.-based provider of products and services for gene function analysis and biomarker discovery, announced the release of its pooled CRISPR Guide RNA (sgRNA) Knockout Library targeting all human protein coding genes. CRISPR technology enables researchers to specifically and permanently "knock out" a gene's function. Cellecta's new Human Whole Genome CRISPR Knockout library provides a high throughput screening tool so that researchers can investigate in a single experiment how human cells respond to the disruption of each gene across the whole genome.

Cellecta is the first company to produce a lentiviral based CRISPR library that targets all of the almost 20,000 protein encoding genes in the human genome. While limited amounts of CRISPR libraries made in academic labs are currently available to some researchers, the small amounts provided require weeks of preparative work before the libraries can be packaged as viral particles and used for gene knockout screens. Cellecta uniquely offers large enough portions of the library for immediate viral packaging. In addition, Cellecta is the only provider to offer the library as pre-packaged lentiviral particles that can be used for a knockout screen immediately on receipt.

Cellecta's library was designed as three modules each targeting approximately a third of the human genome with eight sgRNAs per gene, which is a higher number than most other libraries use. In addition, the sgRNAs in Cellecta's library incorporate improved design features that increase their effectiveness and they have been filtered to ensure they are unique for each gene target to minimize false positive results.

Depending on the needs of the experiment, each of the three CRISPR Library modules can be used separately or combined for a single genome-wide knockout screen. The modular format is similar to Cellecta's Human Genome-Wide shRNA Library, and each of the CRISPR and RNAi Library modules target the same sets of genes so that investigators can more easily make use of both techniques for genome-wide loss of function screens.

"Our intention is to provide a high quality tool to help accelerate the understanding of which genes play key roles in biological responses and disease pathology." said Alex Chenchik, the founder and Chief Scientific Officer of Cellecta. "As has been shown by recent publications and in-house screening work we have done," he continued, "CRISPR mediated knockout provides a powerful approach for these type of screens and we developed this genome-wide library to enable more researchers to utilize this new technology."

About Cellecta:
Cellecta, Inc., a leading provider of genomics products and services, focuses on RNAi and CRISPR technologies for the discovery and characterization of novel therapeutic targets, and genetic profiling for biomarker discovery. The well-cited functional genomicsportfolio offers gene knock-out and knock-down screens, custom and genome-wide RNAi and CRISPR libraries, cell engineering, RNAi and CRISPR construct services, and mutation and expression profiling of cancer samples. 

Contact:
Paul Diehl, Ph.D.
Director, Business Development
Cellecta, Inc.  |  320 Logue Ave  |  Mountain View, CA 94043
T: (650) 938-4050  |  F: (650) 938-3911
pauld@cellecta.com
www.cellecta.com

Logo - http://photos.prnewswire.com/prnh/20150729/249433LOGO 

 


'/>"/>
SOURCE Cellecta, Inc.
Copyright©2015 PR Newswire.
All rights reserved

Related biology news :

1. Synaptics Announces Sampling of Second Generation TDDI Solutions
2. Synaptics Announces Worlds First Match-in-Sensor Fingerprint Authentication Technology
3. ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint
4. KeyLemon Announces Partnership With Biometric Password Solution onefacein
5. Securus Announces Patent Issued for Authorized Presence Verification During Video Visitation
6. Intrexon Announces Distribution Ratio for Distribution of ZIOPHARM Shares
7. NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May
8. The Sync Project Announces Partnership with Berklee College of Musics Institute for Creative Entrepreneurship
9. NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award
10. Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers
11. American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2020)... ... July 01, 2020 , ... ... 1a findings of Neihulizumab, a biologic for the treatment of steroid-refractory acute graft-versus-host ... by hemato-oncologist Dr. Paul J Martin of the Fred Hutchinson Cancer Research Center, ...
(Date:7/1/2020)... ... July 01, 2020 , ... Cure Glioblastoma, ... glioblastoma—the most common and aggressive adult brain cancer—announced today the appointments of its ... are charged with supporting the organization’s initiatives and overall vision. , "Senior Fellows ...
(Date:6/25/2020)... ... June 24, 2020 , ... eClinical Solutions ... data services that accelerate drug development, is collaborating with Karyopharm Therapeutics (Nasdaq: ... hospitalized patients with severe COVID-19. This is the first study of an XPO1 ...
Breaking Biology News(10 mins):
(Date:7/1/2020)... ... 2020 , ... MedShift , a leading medical technology ... obstacles created as a result of COVID-19. As a provider at the forefront ... and medical manufacturers by expanding access to device offerings, technology services, and marketing ...
(Date:7/1/2020)... ... June 30, 2020 , ... ... launch of a new clinical diagnostics immuno-oncology service, TissueInsight . TissueInsight ... , “Flagship’s TissueInsight is a service that aids pathologists, oncologists, and immunologists ...
(Date:6/28/2020)... ... 25, 2020 , ... With the COVID-19 pandemic impacting millions ... In an effort to better understand the cellular responses to COVID-19, the digital ... portraying therapeutic compound effects from over 1,600 approved and referenced molecules on SARS-CoV-2-infected ...
(Date:6/28/2020)... ... June 26, 2020 , ... The Security Industry ... its strong opposition to the recently introduced bicameral Facial Recognition and Biometric ... most federal use of nearly all biometric and related image analytics technologies, incorrectly ...
Breaking Biology Technology: